Zentek (CVE:ZEN) Shares Up 0.6% – Should You Buy?

Zentek Ltd. (CVE:ZENGet Free Report) shot up 0.6% on Wednesday . The company traded as high as C$1.59 and last traded at C$1.57. 26,167 shares traded hands during trading, a decline of 49% from the average session volume of 50,822 shares. The stock had previously closed at C$1.56.

Zentek Stock Down 0.3 %

The company has a current ratio of 2.20, a quick ratio of 7.59 and a debt-to-equity ratio of 5.91. The firm’s fifty day moving average price is C$1.27 and its 200-day moving average price is C$1.29. The company has a market cap of C$165.44 million, a price-to-earnings ratio of -13.25 and a beta of 0.77.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

Featured Articles

Receive News & Ratings for Zentek Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zentek and related companies with MarketBeat.com's FREE daily email newsletter.